Literature DB >> 3020264

Primary cytomegalovirus infection in pregnancy. Incidence, transmission to fetus, and clinical outcome.

S Stagno, R F Pass, G Cloud, W J Britt, R E Henderson, P D Walton, D A Veren, F Page, C A Alford.   

Abstract

We studied 16 218 pregnant women from two income groups to determine the incidence of primary cytomegalovirus (CMV) infection and its consequences for the offspring. In the high-income group, 64.5% of the women were seronegative for CMV and 1.6% had primary CMV infection. In the low-income group, only 23.4% of the women were seronegative for CMV, but 3.7% experienced a primary infection. The rate of transmission in utero was similar in the two groups (39% and 31%). Congenital infections were more frequent in the low-income group; however, primary CMV accounted for 25% of the congenital infections in this group, in contrast to 63% of the high-income cases. Infections acquired early and late in gestation had similar rates of transmission in utero, but three infants (8%) with symptomatic congenital infection and five infants (13.5%) who have developed significant handicaps were exposed in the first half of pregnancy. Primary CMV infection during pregnancy poses a 30% to 40% risk of intrauterine transmission and adverse outcome is more likely when infection occurs within the first half of gestation.

Entities:  

Mesh:

Year:  1986        PMID: 3020264

Source DB:  PubMed          Journal:  JAMA        ISSN: 0098-7484            Impact factor:   56.272


  174 in total

1.  Risk of acquiring cytomegalovirus infection while working in out-of-home child care centres.

Authors:  B Law
Journal:  Can J Infect Dis       Date:  1992-07

2.  Cytomegalovirus (CMV) seroprevalence in pregnant women, bone marrow donors and adolescents in Germany, 1996-2010.

Authors:  Gisela Enders; Anja Daiminger; Lisa Lindemann; Frank Knotek; Ursula Bäder; Simone Exler; Martin Enders
Journal:  Med Microbiol Immunol       Date:  2012-03-08       Impact factor: 3.402

Review 3.  Congenital cytomegalovirus infection after recurrent infection: case reports and review of the literature.

Authors:  Michael A Gaytant; G Ingrid J G Rours; Eric A P Steegers; Jochem M D Galama; Ben A Semmekrot
Journal:  Eur J Pediatr       Date:  2003-02-13       Impact factor: 3.183

4.  Listeriosis in the pregnant guinea pig: a model of vertical transmission.

Authors:  Anna I Bakardjiev; Brian A Stacy; Susan J Fisher; Daniel A Portnoy
Journal:  Infect Immun       Date:  2004-01       Impact factor: 3.441

5.  Evaluation on clinical application of three testing methods for human cytomegalovirus infection in pregnancy.

Authors:  Wanjiang Zeng; Liangzhen Wen; Suhua Chen; Xiazhen Ling
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2003

Review 6.  Controversies in the natural history of congenital human cytomegalovirus infection: the paradox of infection and disease in offspring of women with immunity prior to pregnancy.

Authors:  William Britt
Journal:  Med Microbiol Immunol       Date:  2015-03-13       Impact factor: 3.402

7.  A comparative study of congenital and postnatally acquired human cytomegalovirus infection in infants: lack of expression of viral immediate early protein in congenital cases.

Authors:  A Maeda; T Sata; Y Sato; T Kurata
Journal:  Virchows Arch       Date:  1994       Impact factor: 4.064

8.  Vaccine prevention of maternal cytomegalovirus infection.

Authors:  Robert F Pass; Changpin Zhang; Ashley Evans; Tina Simpson; William Andrews; Meei-Li Huang; Lawrence Corey; Janie Hill; Elizabeth Davis; Cynthia Flanigan; Gretchen Cloud
Journal:  N Engl J Med       Date:  2009-03-19       Impact factor: 91.245

9.  Fetal cytomegalovirus infection of the brain: the spectrum of sonographic findings.

Authors:  Gustavo Malinger; Dorit Lev; Neriman Zahalka; Zahi Ben Aroia; Nathan Watemberg; Deborah Kidron; Liat Ben Sira; Tally Lerman-Sagie
Journal:  AJNR Am J Neuroradiol       Date:  2003-01       Impact factor: 3.825

10.  Optic nerve hypoplasia in North America: a re-appraisal of perinatal risk factors.

Authors:  Pamela Garcia-Filion; Cassandra Fink; Mitchell E Geffner; Mark Borchert
Journal:  Acta Ophthalmol       Date:  2008-12-24       Impact factor: 3.761

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.